ACCMED-eCOA

Rare Disease Day | One in a Million, Yet Never Alone

Although the global incidence of individual rare diseases ranges from 0.065% to 0.1%, the vast spectrum of over 7,000 conditions creates a striking reality: "Rare diseases are not that rare." Globally, the number of patients exceeds 300 million. In China, nearly 20 million people are affected, with the patient population growing at an annual rate of over 10%.

Learn More

ACCMED-eCOA

ACCMED-eCOA Intelligent eCOA Tool

AI-powered eCOA meets therapeutic area standards while adapting to the individualized needs of specific studies. AI-enhanced dynamic testing not only reduces validation time but also ensures data accuracy and consistency. For global trials and multilingual environments, AI-driven optimization supports adaptability across diverse cultures and contexts.

Learn More

ACCMED-eCOA

Not Just Digitization: These Are the Core Strengths of ePRO/eCOA!

Learn More

ACCMED-eCOA

Alzheimer's Striking the Young? Clinical Trials Unveil New Hope Against Early-Onset Dementia

There exists a disease that silently erodes humanity's most precious asset—memory. This is Alzheimer's disease (AD), a silent storm that not only gradually devours patients' memories and cognitive abilities but also leaves families trapped in a cycle of endless loss, their hearts filled with profound struggle and reluctance to let go.

Learn More

ACCMED-eCOA

World Sight Day | Seeing is Believing: Unlocking the Secrets of Ophthalmic Drug Innovation

With increasing ocular burden and global aging trends, the incidence of ocular diseases has surged globally in recent years, driving rapid expansion of the pharmaceutical market. Frost & Sullivan data indicates the global ophthalmic drug market grew from $27.7 billion in 2016 to $35 billion in 2020, with projections reaching $42.5 billion by 2025 and $73.4 billion by 2030.

Learn More

ACCMED-eCOA

World Allergy Day | The Allergy Crisis You Can’t Ignore

Allergic diseases occupy a paradoxical space—ubiquitous yet underestimated. Persistent sneezing, intractable pruritus, and sleepless nights—have these ever etched themselves into your personal narrative?

Learn More